iFR

Videos

Webinars

Round Table Discussions

Live Streams

Use of Intravascular Ultrasound in the Assessment of Chronic Total Occlusions

Use of Intravascular Ultrasound in the Assessment of Chronic Total Occlusions

Video On Demand

Monday 03rd July 2017 @ 16:00 (BST)

Performed By
Prof. Gerald Werner
This educational initiative is supported by
Philips Volcano
 

Prof. Gerald Werner (Klinikum Darmstadt, Germany) presents this webinar on the use of IVUS imaging for the assessment of chronic total occlusions.

This webinar is intended to educate interventional cardiologists, interventional fellows and related healthcare professionals, and discusses and analyses the role of intravascular imaging during PCI for chronic total occlusions, focusing on the main applications in this context from lesion assessment to stent sizing and optimisation.

The webinar/clinical case scenarios will:

  • Provide the background for chronic total occlusions and its treatment
  • Identify the challenges associated with use of PCI for chronic total occlusions
  • Highlight the role and use of IVUS in PCI, including rationale for its use versus coronary angiography
  • Discuss clinical evidence for the use of IVUS in chronic total occlusions
  • Present a workflow algorithm, outlining the steps involved in the practical use of IVUS in chronic total occlusions, in different scenarios (for different approaches such as antegrade and retrograde approaches and for stent optimisation)
  • Discuss real-life case studies, incorporating the relevant components of the workflow algorithm relating to each case

This webinar is to inform and educate interventional cardiologists and cardiologists on:

  • Interventions historically and currently used for the treatment of chronic total occlusions
  • Challenges associated with existing intervention for chronic total occlusions
  • The advantages and roles of IVUS imaging in chronic total occlusion interventions
  • Clinical evidence to support the use of IVUS in the chronic total occlusion setting
  • A workflow algorithm developed to facilitate operators in using IVUS imaging in the various scenarios of chronic total occlusion intervention
  • Interventional Cardiologists
  • Interventional Fellows
  • Cathlab Nurses Technicians and Managers

Professor Gerald Werner has been Director of Cardiology and Intensive Care at the Darmstadt Clinic, a teaching hospital of the University of Frankfurt, since 2005. This post followed a period of 7 years as Professor of Cardiology at the Friedrich Schiller University Jena, where he was Deputy Director of the Cardiology Department and Head of the catheter laboratory. Prior to this, Professor Werner held other positions at the University of Göttingen (Georgia Augusta) including Consultant in internal medicine-cardiology and Head of the echo cardiology laboratory.

Professor Werner’s research interests focus on the interventional therapy of coronary artery disease, including intravascular ultrasound, chronic total occlusions (CTOs) and collateral physiology, and the applications of lasers in interventional cardiology. He is a pioneer of coronary imaging by ultrasound; his earliest publications in this field date back to 1991, and he was among the first to describe the phenomenon of intramural coronary haematoma, and subintimal vessel pathways during recanalisation of a chronic coronary occlusion. He received the Franz–Maximilian Groedel Award of the German Cardiac Society (GCS) for his work on collateral physiology in CTOs. He has published over 150 original papers and is Fellow of the European Society of Cardiology (ESC), American College of Cardiology (ACC) and the Society of Cardiovascular Angiography and Interventions (SCAI). He is also co-Founder and past-President of the EuroCTO club.

  • Yang SS, et al. Eur Rev Med Pharmacol Sci 2015;19:1101–16
  • Prasad A, et al. J Am Coll Cardiol 2007;49:1611–8;
  • St Goar FG, et al. J Am Coll Cardiol 1991;18:952–8
  • Roy P, et al. Eur Heart J 2008;29:1851–7
  • Furuichi S, et al. Catheter Cardiovasc Interv 2007;70:856–9
  • Nakatani S, et al. Expert Rev Med Devices 2013;10:735–49
  • Authors/Task Force members, Windecker S, et al. Eur Heart J 2014;35:2541–619
  • Chieffo A, et al. Am Heart J 2013;165:65–72
  • Hong SJ, et al. Am J Cardiol 2014;114:534–40
  • Tian NL, et al. EuroIntervention 2015;10:1409–17
  • Kim BK, et al. Circ Cardiovasc Interv 2015;8:e002592

Use of IVUS Imaging in PCI of Left Main Coronary Artery Disease

Use of IVUS Imaging in PCI of Left Main Coronary Artery Disease

Wednesday 15th November 2017 @ 16:00 (GMT)

Video On Demand

Performed By
Prof. Adrian Banning
This educational initiative is supported by  Philips Healthcare

Prof. Adrian Banning (John Radcliffe Hospital, Oxford, UK) presents this webinar on the use of IVUS imaging in percutaneous coronary intervention (PCI) of Left Main Coronary Artery Disease.

This webinar is intended to educate interventional cardiologists, interventional fellows and related healthcare professionals, and discusses and analyses the role of intravascular imaging with intravascular ultrasound in LMCA PCI, focusing on the main applications in this context from lesion assessment to stent sizing and optimisation.

The webinar/clinical case scenarios will:

  • Provide the background for LMCA disease and its treatment, including findings from the SYNTAX study comparing the use of CABG and PCI interventions in the LMCA setting
  • Highlight the role and recommended use of IVUS in interventions for LMCA, including rationale for its use versus coronary angiography
  • Definition of when to use IVUS as determined by validated MLA cut-off values
  • Outline of the use of IVUS imaging for characterisation of LMCA disease and to facilitate stent sizing and stent optimisation
  • Discuss real-life case studies describing IVUS in ostial left main disease and bifurcation left main disease
  • Present a workflow algorithm to guide the operator, in a step-wise manner, on the use of IVUS applications in the LMCA setting

This webinar is to inform and educate interventional cardiologists and cardiologists on:

  • Interventions historically and currently used for the treatment of LMCA disease
  • The role of IVUS imaging in LMCA interventions
  • When IVUS imaging should be used and the benefits of its use
  • A workflow algorithm developed to facilitate operators in using IVUS imaging in the LMCA setting
  • Interventional Cardiologists
  • Interventional Fellows
  • Cathlab Nurses Technicians and Managers

Professor Adrian Banning is a Consultant Cardiologist specialising in percutaneous coronary intervention. He is the President of the British Cardiac Intervention Society and previously held the position of Divisional Director of Cardiology, Cardiothoracic and Vascular Surgery at the John Radcliffe Hospital in Oxfordshire. He also works from his own private practice at The Manor Hospital also based in Oxford, UK.

He began his career as a Senior Registrar at the John Radcliffe University Hospital in 1995, he became a consultant cardiologist in 1999 and subsequently Clinical Lead and Divisional Director in 2010.

A research pioneer, expert lecturer and advisor, Prof Banning is an established author who has written many scientific papers and textbooks in this area.

  • Morice MC, et al. Circulation 2010;121:2645–53
  • Windecker S, et al. Eur Heart J 2014;35:2541–619
  • Campos CM, et al. EuroIntervention 2015;11 Suppl V:115–9
  • Jasti V, et al. Circulation 2004;110:2831–6
  • de la Torre Hernandez JM, et al. J Am Coll Cardiol 2011;58:351–8
  • Kang SJ, et al. Catheter Cardiovasc Interv 2014;83:545–52
  • Tuzcu EM, et al. J Am Coll Cardiol 1996;27:832–8
  • Mintz GS, et al. Circulation 1995;91:1959–65

Transradial Coronary Artery Procedures: Tips for Success

Percutaneous revascularisation has become the cornerstone of ischaemic heart disease management.1,2 Historically, coronary angiography and intervention was predominantly performed via the common femoral artery.3 However, this procedure has an associated 1.5–9.0 % risk of complications, most of which are related to bleeding at the femoral access site.4 Despite a significant reduction in the incidence of major femoral bleeding complications during 1994 to 2005 from 8.4 % to 3.5 %, respectively,5 related to technological advancement